Ciprofloxacin-induced torsade de pointes

被引:15
作者
Flanagan, M. Casey
Mitchell, Eric S.
Haigney, Mark C. P. [1 ]
机构
[1] Natl Naval Med Ctr, Dept Internal Med, Bethesda, MD USA
[2] Natl Naval Med Ctr, Dept Cardiol, Bethesda, MD USA
[3] Uniformed Serv Univ Hlth Sci, Div Cardiol, Bethesda, MD 20814 USA
关键词
ciprofloxacin; torsade de pointes; QT interval;
D O I
10.1016/j.ijcard.2005.08.048
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We report a rare case of torsade de pointes, a polymorphic ventricular tachycardia, associated with QT interval prolongation, caused by intravenous ciprofloxacin given for pneumonia in a 22-year-old healthy Marine. Although the risk for quinolone-associated torsade de pointes appears to be low, caution is still warranted when given in the presence of pre-existing QT prolongation. Published by Elsevier Ireland Ltd.
引用
收藏
页码:239 / 241
页数:3
相关论文
共 7 条
[1]   Torsades de pointes associated with fluoroquinolones: Importance of concomitant risk factors [J].
Amankwa, K ;
Krishnan, SC ;
Tisdale, JE .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (03) :242-247
[2]  
*BAYER LAB, 2004, CIPR INF
[3]  
*BAYER LAB, 2002, CIPR OR SUSP
[4]   Gatifloxacin-associated corrected QT interval prolongation, Torsades de pointes, and ventricular fibrillation in patients with known risk factors [J].
Bertino, JS ;
Owens, RC ;
Carnes, TD ;
Iannini, PB .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (06) :861-863
[5]   Rates of Torsades de Pointes associated with ciprofloxacin, ofloxacin, levofloxacin, gatifloxacin, and moxifloxacin [J].
Frothingham, R .
PHARMACOTHERAPY, 2001, 21 (12) :1468-1472
[6]   Drugs and the QT interval - Caveat doctor [J].
Liu, BA ;
Juurlink, DN .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (11) :1053-1056
[7]   Long QT syndromes and torsade de pointes [J].
Viskin, S .
LANCET, 1999, 354 (9190) :1625-1633